| Analysis | Metabolite Name | Measured Value | Units | Group | Treatment | Sample Source |
|---|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | L-Serine | 4.1 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 4.2 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 4.2 | uL(plasma), pmole/mg (muscle) | batch1 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 4.3 | uL(plasma), pmole/mg (muscle) | batch1 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 4.4 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 4.7 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 4.7 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 5.1 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 5.1 | uL(plasma), pmole/mg (muscle) | batch1 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 5.2 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 5.2 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 5.4 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 5.8 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 5.8 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 5.9 | uL(plasma), pmole/mg (muscle) | batch1 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 6.3 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 6.4 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 6.5 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 6.7 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 6.8 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 7 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 7.3 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 7.6 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 7.7 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 7.8 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 8.4 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 8.4 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 9 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 9.5 | uL(plasma), pmole/mg (muscle) | batch1 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 10.6 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Serine | 47 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 49.1 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 52.6 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 54.7 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 59.9 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 61.5 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 62.8 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 62.9 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 63.7 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 65.5 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 67.3 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 67.8 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 67.9 | uL(plasma), pmole/mg (muscle) | batch1 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 68.5 | uL(plasma), pmole/mg (muscle) | batch1 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 69.8 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 71.6 | uL(plasma), pmole/mg (muscle) | batch1 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 73.2 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 74.7 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 74.9 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 79.2 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 81.4 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 84.8 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 87.2 | uL(plasma), pmole/mg (muscle) | batch1 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 87.4 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 96.2 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 106 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 106 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 109 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 113 | uL(plasma), pmole/mg (muscle) | batch1 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Serine | 116.45 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | plasma |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|